Literature DB >> 30218030

Precision risk-based screening might maximize benefit and minimize harm.

Laura J Esserman1, Andrea Z LaCroix2.   

Abstract

Mesh：

Year:  2018        PMID： 30218030     DOI： 10.1038/s41571-018-0093-0

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

Review 1.  Circulating cell-free DNA for cancer early detection.

Authors:  Qiang Gao; Qiang Zeng; Zhijie Wang; Chengcheng Li; Yu Xu; Peng Cui; Xin Zhu; Huafei Lu; Guoqiang Wang; Shangli Cai; Jie Wang; Jia Fan
Journal:  Innovation (Camb)       Date:  2022-05-06

2.  Cervical Cancer in the Baltic States: Can Intelligent and Personalized Cancer Screening Change the Situation?

Authors:  Mindaugas Stankūnas; Kersti Pärna; Anna Tisler; Anda Ķīvīte-Urtāne; Una Kojalo; Jana Zodzika; Nicholas Baltzer; Jan Nygard; Mari Nygard; Anneli Uuskula
Journal:  Acta Med Litu       Date:  2022-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.